Quotient Limited Announces Departure of Chief Operating Officer
22. Dezember 2020 16:05 ET
|
Quotient Limited
JERSEY, Channel Islands, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that on December 21, 2020, Ed Farrell...
Quotient Limited Provides Status Update on the Initial SDS Microarray and MosaiQ Instrument for the US Market
10. Dezember 2020 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that it received a request from the...
Quotient Limited Announces MosaiQ™ Expanded IH EU Field Trial Performance Data
30. November 2020 16:05 ET
|
Quotient Limited
JERSEY, Channel Islands, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported preliminary EU field trial performance...
Quotient Limited to Participate in Two Upcoming Conferences
09. November 2020 16:05 ET
|
Quotient Limited
JERSEY, Channel Islands, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland,...
Quotient Limited Reports Second Quarter Fiscal 2021 Results and Business Update
02. November 2020 06:00 ET
|
Quotient Limited
FDA Emergency Use Authorization for the MosaiQ COVID-19 antibody test receivedFDA 510(k) clearance for Initial MosaiQ SDS microarray and MosaiQ instrument expected before the end of CY2020European...
Quotient Limited to Report Second Quarter 2021 Financial Results and Host Conference Call
19. Oktober 2020 08:48 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second...
Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody test
28. September 2020 07:00 ET
|
Quotient Limited
JERSEY, Channel Islands, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S. Food and Drug...
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
15. September 2020 16:05 ET
|
Quotient Limited
JERSEY, Channel Islands, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced the closing of its previously...
Quotient Limited Announces Upsize and Pricing of Underwritten Offering of Ordinary Shares
10. September 2020 20:42 ET
|
Quotient Limited
JERSEY, Channel Islands, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the Company), a commercial-stage diagnostics company, today announced the upsize and pricing of a $75...
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
09. September 2020 16:05 ET
|
Quotient Limited
JERSEY, Channel Islands, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an...